Physician profile
William Bonner
NPI 1750309597
$597.32
in general payments reported to CMS, 2019-2025
12 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.83 · 2022: $33.88 · 2023: $23.36 · 2024: $282 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $159.20 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $85.37 | 2024 | Vevye |
| Sun Pharmaceutical Industries INC. | $79.08 | 2024 | |
| Bausch & Lomb Americas INC. | $44.81 | 2023-2024 | Miebo, Ic-8 Apthera Iol, Envista Mx60 Iol |
| Oyster Point Pharma, INC. | $44.78 | 2024-2025 | Tyrvaya |
| Glaukos Corporation | $43.04 | 2024 | Idose |
| Amgen INC. | $31.75 | 2025 | Tepezza |
| Dompe US, INC. | $29.70 | 2024-2025 | Oxervate |
| Rxsight INC | $24.88 | 2025 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Coopervision INC. | $20.83 | 2019 | |
| Abbvie INC. | $18.04 | 2022 | |
| Biotissue Holdings INC. | $15.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bonner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.